- Home
- TVTX vs NATL Comparison
TVTX vs NATL Comparison
Compare TVTX & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- NATL
- Stock Information
- Founded
- TVTX 2008
- NATL 2023
- Country
- TVTX United States
- NATL United States
- Employees
- TVTX N/A
- NATL N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- NATL
- Sector
- TVTX Health Care
- NATL
- Exchange
- TVTX Nasdaq
- NATL Nasdaq
- Market Cap
- TVTX 1.7B
- NATL 1.8B
- IPO Year
- TVTX N/A
- NATL N/A
- Fundamental
- Price
- TVTX $15.02
- NATL $26.52
- Analyst Decision
- TVTX Strong Buy
- NATL Buy
- Analyst Count
- TVTX 14
- NATL 3
- Target Price
- TVTX $33.31
- NATL $40.00
- AVG Volume (30 Days)
- TVTX 1.9M
- NATL 392.8K
- Earning Date
- TVTX 05-01-2025
- NATL 05-07-2025
- Dividend Yield
- TVTX N/A
- NATL N/A
- EPS Growth
- TVTX N/A
- NATL N/A
- EPS
- TVTX N/A
- NATL 1.55
- Revenue
- TVTX $273,533,000.00
- NATL $4,247,000,000.00
- Revenue This Year
- TVTX $74.41
- NATL $1.81
- Revenue Next Year
- TVTX $48.90
- NATL $4.37
- P/E Ratio
- TVTX N/A
- NATL $17.10
- Revenue Growth
- TVTX 75.65
- NATL N/A
- 52 Week Low
- TVTX $6.79
- NATL $22.30
- 52 Week High
- TVTX $25.29
- NATL $35.50
- Technical
- Relative Strength Index (RSI)
- TVTX 35.45
- NATL 47.24
- Support Level
- TVTX $16.37
- NATL $25.37
- Resistance Level
- TVTX $15.48
- NATL $28.12
- Average True Range (ATR)
- TVTX 1.00
- NATL 0.81
- MACD
- TVTX -0.51
- NATL -0.14
- Stochastic Oscillator
- TVTX 3.83
- NATL 39.66
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.